Abcuro Secures $200M Series C to Advance Ulviprubart for IBM
Key Highlights Abcuro raises $200M in Series C funding led by New Enterprise Associates (NEA) with participation from…
Browsing Tag
Samsara Biocapital
5 posts
OrsoBio Closes $67 Million Series B Financing to Advance Obesity Therapies
Key Highlights OrsoBio secures $67M Series B financing, led by Ascenta Capital and Woodline Partners. Proceeds will accelerate…
Enlaza Therapeutics Secures $100M in Series A Funding
Key Highlights $100 million Series A funding led by J.P. Morgan Asset Management’s Private Capital. Funding to develop proprietary covalent…
Seismic Therapeutic Secures $121 Million in Series B Funding for Advanced Immunology Drug Development
Key Highlights Seismic Therapeutic, Inc., a machine learning immunology company, announces a $121 million Series B financing, led by Bessemer Venture…
EyeBio Secures $130 Million in Extended Series A Funding, Paving the Way for Advanced Retinal Disease Therapies
Key Highlights Significant Funding Achievement: EyeBio successfully closes an extension to its Series A financing, totaling $130 million. Strategic…